Effects of Combined Sevoflurane and Nitrous Oxide Inhalation - 14

NCT00000262 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Opioid-Related Disorders
Substance-Related Disorders

Interventions

DRUG: 30% Nitrous oxide
DRUG: 0.4% Sevoflurane
DRUG: 0.2% sevoflurane
OTHER: Placebo

Sponsor

University of Chicago

Collaborators

[object Object]